Articles by Disease (Renal Cell Carcinoma)

PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress

Journal: Current Medicinal Chemistry
Volume: 17
Page: 4326-4341
Author(s): P. Wu and Y.-Z. Hu

PI3K/AKT/mTOR Inhibitors In Ovarian Cancer

Journal: Current Medicinal Chemistry
Volume: 17
Page: 4433-4447
Author(s): M. Mazzoletti and M. Broggini

The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia

Journal: Current Medicinal Chemistry
Volume: 17
Page: 4448-4461
Author(s): K. J. Hatfield, H. Reikvam and O. Bruserud

MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 8
Page: 289-305
Author(s): William Xu, Qi Zhao Wang, Qi Cui and Ruian Xu

Optimizing Tumor-Reactive γδT Cells for Antibody-Based Cancer Immunotherapy

Journal: Current Molecular Medicine
Volume: 10
Page: 719-726
Author(s): S. Meraviglia, N. Caccamo, G. Guggino, M. Tolomeo, S. Siragusa, G. Stassi and F. Dieli

Paclitaxel Efficacy is Increased by Parthenolide via Nuclear Factor- KappaB Pathways in In Vitro and In Vivo Human Non–Small Cell Lung Cancer Models

Journal: Current Cancer Drug Targets
Volume: 10
Page: 705-715
Author(s): Z. W. Gao, D. L. Zhang and C. B. Guo

Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer

Journal: Current Cancer Drug Targets
Volume: 10
Page: 772-781
Author(s): S. Perdona, S. Scala, G. Castello, S. Costantini, A. Ottaiano, L. Pucci, N. Longo, G. Carteni, G. Facchini, S. Pignata, C. D'Alterio, L. Claudio, L. Marra, R. Calemma, M. Cioffi, L. Portella, L. Cindolo, R. Franco, M. Polimeno and C. Consales